Vioxx (rofecoxib) for osteoarthritis, acute pain, and primary dysmenorrhea

Merck Frosst is now introducing Vioxx (rofecoxib) for osteoarthritis, acute pain, and primary dysmenorrhea.

It's a new COX-2 inhibitor...similar to Celebrex (celecoxib).

Vioxx and Celebrex are comparable to NSAIDs for reducing pain and inflammation...but the new drugs MIGHT cause fewer ulcers.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote